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Specialty Update
What’s New in Spine Surgery
By Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Alexander R. Vaccaro, MD, and Jeffrey C. Wang, MD
What’s New in the Treatment of the Cervical Spine
Cervical Disc Arthroplasty
Three cervical disc arthroplasty devices are currently approved
for patient care in the United States. There are different kine-
matic designs (ball and socket, ball and trough, and mobile
center core) and different bearing couples (stainless steel metal
on metal, cobalt-chromium on polyethylene, and titanium
on polycarbonate-polyurethane). Other designs with cobalt-
chromium metal-on-metal bearing surfaces are also being in-
vestigated in pivotal clinical trials. No clinical differences are
apparent between these devices at this time. The four and five-
year results of randomized clinical trials comparing arthrodesis
with arthroplasty after decompression for the treatment of
single-level cervical disease have shown equal or better results
following arthroplasty as compared with arthrodesis in terms
of overall clinical success, pain, and functional improvement,
and the results have been stable over time. Revision rates of
2% to 5% have been seen following arthroplasty, and in these
trials no device failures or wear-associated complications have
been observed. Pooled data indicate that the rates of reopera-
tion are significantly higher following arthrodesis, at both
the index and adjacent levels. Two cases of apparent metal
hypersensitivity causing a pseudotumor with symptomatic
spinal cord compression following the placement of a cobalt-
chromium metal-on-metal cervical prosthesis have been re-
ported. These cases were similar to the pseudotumor reactions
seen in some patients following metal-on-metal total hip
arthroplasty.
Anterior Cervical Discectomy and Fusion
Anterior cervical discectomy and fusion remains the most
common surgical procedure involving the cervical spine and
is associated with a high level of patient satisfaction. Com-
parative effectiveness and cost-effectiveness studies also have
demonstrated the value of this procedure in comparison
with the treatment of other orthopaedic and general medical
diseases. A longitudinal National Inpatient Database study
demonstrated that the total number of dollars spent for ante-
rior cervical spine surgery increased sixfold from 1992 to
2005 despite the hospital stay decreasing by half. Surgical
procedures for patients with more comorbidities are being
increasingly performed. When the Short Form (SF)-36 was
used to assess outcomes, improvement after cervical arthro-
plasty and arthrodesis was equal to that after total hip or total
knee arthroplasty. Evaluating procedural costs is difficult and
varies widely, but in one report at a single institution, up to
a fivefold variation of costs occurred for single-level cervical
fusions. The cost disparities were related to variation in the
length of hospital stay and the surgeon’s choice of medical
equipment, including implant cost. Costs were inversely
proportional to the volume of surgery as patients of high-
volume surgeons had shorter length of stay and lower equip-
ment costs. Given the limited clinical data supporting one
device over another, surgeons should consider cost when se-
lecting these implants.
The United States Food and Drug Administration (FDA)
sent a warning letter in July 2008 regarding the use of re-
combinant human bone morphogenetic protein-2 (rhBMP-2)
for anterior cervical spine surgery because there had been
many reports of postoperative severe dysphagia, dysphonia,
hematoma, and airway obstruction. These problems were
confirmed in a randomized clinical trial in which rhBMP-2
was compared with ceramic bone filler, with both being
placed into a cage along with an anterior cervical plate. The
BMP-2 was associated with significantly greater dysphagia
scores, requirement for steroids to reduce retropharyngeal
swelling, and ectopic bone posterior to the cage toward the
spinal cord and at adjacent levels, without any observable
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difference in fusion. Bioabsorbable plates have been used, but
the results of a small observational cohort were disappointing,
showing early failure, graft collapse and extrusion, pseud-
arthrosis, and segmental kyphosis in more than half of the
patients.
Cervical Myelopathy
No consensus has been reached in determining the choice
of either anterior or posterior approach for the surgical treat-
ment of cervical myelopathy. The choice will depend on many
factors such as the number of involved levels, the cause of
compression, spinal alignment, comorbidities, and the sur-
geon’s experience and ability. In a large international multi-
center observational study, investigators found significant
improvement in all outcome measures for patients managed
with both anterior and posterior approaches.
The management of patients who have mild symptom-
atic myelopathy or those who have cervical stenosis without
neurologic symptoms remains controversial. It is unknown if
surgical decompression will lead to improved outcomes and
will prevent deterioration or spinal cord injury with sub-
sequent trauma. Sumi et al. reported on seventy patients with
mild cervical spondylotic myelopathy who were managed
nonoperatively for five years. Deterioration occurred in 25%
of the patients, the majority of whom were subsequently
managed surgically. In these cases, severe cord compression
was present initially and magnetic resonance imaging dem-
onstrated a triangular deformity of the spinal cord, a finding
that may warrant earlier surgical decompression. The need
for earlier surgical decompression was confirmed in a Euro-
pean study that examined the natural history of cervical
myelopathy due to long surgical waiting lists. Patients with
myelopathy had to wait more than twenty months for surgery;
more than two-thirds of these patients had deterioration
in terms of pain and function and half had deterioration
as demonstrated by objective neurologic examination. Only
one patient had improvement despite having no active
treatment.
Another concern in patients with cervical cord com-
pression is the chance of catastrophic spinal cord injury re-
sulting from low-energy trauma. In a Japanese multicenter
study, 453 patients with acute traumatic spinal cord injury were
reviewed. Of these, 25% had ossification of the posterior lon-
gitudinal ligament and did not have associated bone injury.
Half of the patients had clinical symptoms prior to acute spinal
cord injury, such as gait disturbance, and only one-quarter of
the patients were aware of the diagnosis of ossification of the
posterior longitudinal ligament. The mechanism of spinal cord
injury was a fall in >70% of the cases. Although this study
did not answer the question of whether prophylactic de-
compression will reduce risk of spinal cord injury in patients
with asymptomatic spinal cord compression, certainly patients
with symptomatic myelopathy such as ataxia are at risk for
spinal cord injury with subsequent trauma.
What’s New in Biologic Topics Related to the Spine
Introduction
Biologics continue to be a major focus in spinal research and
the development of new products for patients with spinal
disorders today. The majority of the clinical attention remains
on bone formation, but laboratory efforts continue to in-
vestigate the role of biologics in retarding or reversing in-
tervertebral disc degeneration. In patients undergoing spinal
fusion, the choice of bone-graft substitutes remains an im-
perfect process, made difficult by the paucity of clinical data,
a preponderance of anecdotal information and marketing, and
the reality of price differences between materials. Regardless,
the desire to eliminate the need for autogenous iliac crest bone
graft harvest remains strong, and the use of biologics is on
the rise. Since the FDA’s post-marketing approval of recombi-
nant human bone morphogenetic protein-2 (rhBMP-2) in
2002 and Humanitarian Device Exemption for rhBMP-7 late in
2004, the majority of new studies have continued to focus on
the clinical performance and local side effects resulting from
physician-directed use of rhBMP-2. A recent survey in the
United States estimated that BMPs were used in 25% of spinal
fusions in 2006.
Recombinant Osteoinductive Proteins
In the past year, there were no reports of new clinical studies
on spinal fusion using rhBMP-7 (OP-1; Stryker, Hopkinton,
Massachusetts). This biologic failed to achieve post-marketing
approval for posterolateral spine fusion in 2009. A study of
rat fracture repair demonstrated that OP-1 could mitigate the
inhibitory effects of glucocorticoid exposure, suggesting that
BMPs may be effective even in patients taking steroids. How-
ever, it is not clear if higher concentrations of BMPs will be
required in such situations clinically.
Although rhBMP-2 (INFUSE; Medtronic Spinal &
Biologics, Memphis, Tennessee) has received FDA approval for
anterior lumbar interbody fusion, several physician-directed
and Investigational Device Exemption studies have demon-
strated outcomes of transforaminal and posterior interbody
spine fusions as well as posterolateral spine fusion. A pilot study
involving forty-six patients investigated the use of an rhBMP-
2/collagen sponge with ceramic granules as a bulking agent
inside the sponge for posterolateral lumbar spine fusion. This
technique yielded a 95% radiographic fusion rate in the BMP
group, compared with a 70% fusion rate when iliac crest
bone graft was used alone. Another report involving 463
patients undergoing scoliosis surgery described the use of
rhBMP-2 with an optimized compression-resistant matrix
instead of a collagen sponge, resulting in a 96% fusion success
rate as compared with an 89% rate for patients managed with
iliac crest bone graft.
Another important application for BMPs is long spinal
deformity fusion. The acquisition of adequate iliac crest bone
graft in such cases is consistently a challenge. One report
from a major spinal deformity surgical center described the
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successful use of rhBMP-2/collagen in these patients, with an
average rhBMP-2 dose of 10.0 mg/level for posterior fusions
and 11.6 mg/level for anterior fusions. This study demon-
strated a pseudarthrosis rate of 28% in patients who received
iliac crest bone graft and of only 4% in the patients who re-
ceived rhBMP-2.
A primary concern with physician-directed use of re-
combinant BMPs continues to focus around local adverse
events. The most commonly reported local side effects are
heterotopic bone formation in the surgical approach track,
transient radiculitis, transient vertebral body bone resorption
when used near exposed cancellous bone, and sterile seroma
fluid collections and/or local edema. Most of these local side
effects are believed to be related to use of excessive BMP, either
by increasing the concentration of the growth factor on the
carrier sponge or overfilling the defect with the BMP sponge
composite, resulting in a higher concentration or leakage of
BMP into the surrounding tissues. BMP-induced radiculitis
typically occurs seven to ten days following surgery and persists
for a variable length of time.
Although no prospective studies have yet been reported,
anecdotal publications have described two methods to poten-
tially lower the risk of these local side effects, particularly
with posterior lumbar interbody fusion and transforaminal
lumbar interbody fusion procedures. One report on seventeen
patients undergoing posterior lumbar interbody fusion with
PEEK (polyetheretherketone) cages and 6 mg of rhBMP-2 per
cage described no clinical side effects but described some
transient radiographic resorption of the vertebral end plates.
The general consensus is that lower doses of rhBMP-2/collagen
when used in the interbody space may decrease the compli-
cation rate. A study supporting the dose-dependence of com-
plications, presented at the North American Spine Society
annual meeting but not yet published, involving a subgroup
of patients who received a dose of <1.1 mg of rhBMP-2 per
level for transforaminal lumbar interbody fusion or posterior
lumbar interbody fusion combined with demineralized bone
matrix, demonstrated a 95% fusion rate, with no
complications.
There have been several reports of psoas muscle ossifi-
cation associated with rhBMP-2/absorbable collagen sponge
implantation in the posterolateral spine, but it is believed that
this is uncommon. Nonetheless, there appears to be something
unique about the psoas muscle, compared with other poste-
rior spinal muscles, that may make it more susceptible to BMP-
2-induced heterotopic ossification in some individuals. The
risk factors that lead to this rare side effect are not known but
may involve both genetic predisposition as well as surgical
violation of the intertransverse membrane providing access
to the psoas muscle.
Several authors have previously reported severe peri-
operative swelling in the anterior cervical spine, sometimes
when excessive BMP-2 doses were used or when the BMP was
placed outside the structural cage/implant. This complication
often becomes apparent several days after surgery and has
necessitated reintubation or tracheotomy because of the risk
of respiratory arrest. Surgeons who are experiencing these
local side effects with any regularity should carefully examine
their technique and should avoid the use of excessive amounts
of BMPs in small spaces or overpacking of the BMP im-
plants. Given the high success rate for anterior cervical fusion
in healthy patients managed with allograft and plating, sur-
geons must carefully balance any increased risk of side effects
resulting from the use of BMP in those patients with a higher
risk of nonunion, such as those with diabetes, smokers,
those receiving corticosteroid treatment, or those with multi-
level cervical fusion. A recent survey of complications associ-
ated with spine fusions demonstrated that the use of BMP
in anterior cervical fusion procedures increased the compli-
cation rate from 4.7% to 7.1% and was associated with
greater inpatient hospital charges across all categories of spine
fusion.
Other Bone Graft Substitutes
Although much focus remains on recombinant osteoinductive
proteins, their relatively high cost has continued to encourage
research involving other bone-graft solutions. Platelet-rich
plasma was offered as an autologous growth factor source to
augment bone healing, but it then fell out of favor for use in
spine fusion when several clinical studies demonstrated rela-
tively poor results. A recent study of mouse spine fusions
showed that bone marrow cells were able to augment the effects
of rhBMP-2 but that platelet-rich plasma was unable to do
so. In contrast, a new study demonstrated that platelet-rich
plasma increased the osteoinductivity of demineralized bone
matrix in vivo, but only when the platelet-rich plasma was used
without thrombin activation. This information may prompt
a reevaluation of platelet-rich plasma for augmentation of bone
healing, ideally in carefully controlled preclinical studies.
There is continued interest in the use of mesenchymal
stem cells for bone and cartilage regeneration. In rodent
models, both fat-derived and bone marrow-derived mesen-
chymal stem cells have been proposed for use in spine fusion.
However, spine fusion is a challenging environment in which
to form bone, and a recent study showed that neither bone
marrow aspirate nor mesenchymal stem cell-enriched bone
marrow aspirate was sufficient to heal critical-size femoral
defects in rats. Furthermore, another study demonstrated
that BMP was not able to induce an osteogenic response in
adipose-derived mesenchymal stem cells, suggesting that not
all sources of mesenchymal stem cells may be sufficient for
spine fusion. The clinical future of these strategies that propose
the use of mesenchymal stem cells alone as a biologic grafting
solution for spine fusion remains unclear. The number of
stem cells present in bone marrow is relatively small and var-
iable, and in the absence of specific signals (e.g., BMP) it is not
clear whether sufficient numbers of cells are present to con-
sistently initiate bone formation in spine fusion.
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Biologic Treatments for Disc Degeneration
Progress toward biologic treatments to prevent or retard disc
degeneration or to heal anular defects continued at a slow pace.
Continued animal evidence of beneficial effects of recombi-
nant BMPs (BMP-7, BMP-2, GDF-5) on disc metabolism have
prompted the planning of a clinical trial to investigate the
response in humans, but no results have been published to
date. Indicating that BMPs may have beneficial effects on discs,
an in vitro study demonstrated different effects of BMP-2 on
human anulus fibrosus and nucleus pulposus cells. There was
a mitogenic effect on anulus fibrosus cells and an anabolic
stimulation of proteoglycan synthesis in the nucleus pulposus
cells, with no evidence of bone formation within the disc tissue.
Although the use of biologics to treat disc degeneration is a
long way off from clinical use, it is worth monitoring develop-
ments in this area that could ultimately be applicable for the
treatment and prevention of many degenerative spine disorders.
What’s New in Spinal Deformity Surgery
Idiopathic Scoliosis
There is continued interest in the comparison between ante-
rior and posterior treatment of thoracolumbar and lumbar
adolescent idiopathic scoliosis. Reports comparing the two
methods and analyzing either posterior-only or anterior-only
approaches have indicated that both techniques have merit.
The value of pedicle screws continues to be a point of
investigation. In the idiopathic teenage population, it appears
that maneuvers with pedicle screw constructs provide more
deformity correction and derotation than do hybrid constructs,
hooks-only constructs, or wires-only constructs. It also appears
that derotation maneuvers with pedicle screws provide better
correction than what is seen with hooks. However, it is unclear
whether derotation maneuvers with pedicle screws provide
better three-dimensional correction than other maneuvers
with pedicle screws do. It may be that the enhanced correction
with pedicle screws is due to the coupled effect of translational
to rotational correction.
Bracing for Idiopathic Scoliosis
There continues to be substantial debate about the usefulness
of bracing. One study in which patients who were managed
with bracing were compared with patients who were managed
with observation resulted in interesting conclusions at the time
of long-term follow-up. The patients in the observation group
found their body appearance to be significantly less distorted
than did those in the bracing group. Also, there is some sug-
gestion that patients who are managed with bracing before
posterior fusion and instrumentation for the treatment of
idiopathic scoliosis have reduced satisfaction, lower activity
levels, and more pain two years after surgery than those who
are not managed with bracing preoperatively. Furthermore,
decision-making about who should be managed with bracing
on the basis of genetic factors is being studied and adds an
additional component.
Adult Spinal Deformity
Spinal deformity in adults presents differently on the basis of
age. Patients who are more than sixty years old have signifi-
cantly greater disability and worse health status in comparison
with those who are forty to sixty years old. While patients who
are more than sixty years old have more operative complica-
tions, their incremental improvement in terms of patient-
reported health status following surgical treatment seems
comparable with or slightly higher than that of younger pa-
tients at the time of the two-year follow-up as determined with
outcome-assessment questionnaires. Appropriately selected
patients over the age of sixty years do appear to benefit from
long fusion to the sacrum for the primary treatment of adult
scoliosis. Several emerging studies suggest that nonoperative
treatment, commonly used for patients with adult scoliosis,
results in substantial cost but no improvement in health status.
The NIH R01 study entitled ‘‘A Multicenter Prospective Study
of Quality of Life in Adult Scoliosis (ASLS)’’ (NCT00854828)
is about to begin enrollment.
Biologics
In the past, iliac bone graft has been used for fusion with
posterior instrumentation for the treatment of adolescent
idiopathic scoliosis. Most surgeons and centers are now
trending away from the use of iliac bone graft, using local bone
and allograft instead. One report suggested a high fusion rate
(>95%) in association with the use of local bone and beta-
tricalcium phosphate matrix, without the need for allograft.
Several studies in adults have suggested that, in long
spinal fusions with instrumentation to the pelvis and sacrum,
iliac crest bone graft may not be necessary if rhBMP-2 is
combined with local autograft and allograft. Fusion rates as-
sociated with rhBMP-2 were better than those associated with
iliac bone graft without rhBMP-2 for multilevel fusions per-
formed from either an anterior or a posterior surgical approach
(96% compared with 72% in one study). However, nonunion is
relatively common, particularly at L5-S1, even with anterior
lumbar interbody fusion, transforaminal lumbar interbody
fusion, and protection of sacral screws with iliac screws. Out-
comes associated with transforaminal lumbar interbody fusion
and/or anterior lumbar interbody fusion at L5-S1 seem to be
comparable. Most centers are now performing more selective
anterior fusions of two or three segments. In addition, utilization
of minimally invasive multilevel anterior fusion techniques is
increasing. Clinical and radiographic comparisons of open and
minimally invasive techniques will soon be available.
Infantile and Juvenile Scoliosis
Various techniques are currently being employed to treat
progressive spinal deformity in the infantile and juvenile age
ranges (zero to ten years old). In this population of patients
with early-onset scoliosis, a long fusion negatively impacts
ultimate trunk height and pulmonary maturation. The issues
noted in association with various ‘‘growing rod’’ techniques are
2020
TH E J O U R N A L O F B O N E & JO I N T SU R G E RY d J B J S . O R G
VO LU M E 92-A d NU M B E R 10 d AU G U S T 18, 2010
WH AT ’s NE W I N SP I N E SU R G E RY
What’s New in Spine Surgery
(1) the high prevalence of growing rod fractures, (2) the role
of neuromonitoring for growing rod and rib-based instru-
mentation surgery, (3) the high prevalence of infection and
implant-related pressure sores, (4) the identification of spon-
taneous autofusions, (5) diminishing return with subsequent
lengthening procedures, (6) the ultimate benefit in terms of
pulmonary function, and (7) the true prevalence of neural axis
anomalies in these patients. Currently, all of these issues are
being studied.
Spondylolisthesis
One study reviewed forty-three patients who underwent sur-
gery for the treatment of spondylolisthesis or spondylolysis
between 1984 and 2005 at two institutions and demonstrated
an overall complication rate of 47% after a minimum two-year
follow-up. In this series, a postoperative neurologic deficit
was seen in 12%, 80% of which persisted at the time of the final
follow-up. In the group as a whole, 37% required reoperation
and 5% had wound infections. In children and adolescents,
the complication and reoperation rates following surgery for
the treatment of spondylolisthesis are much higher than those
following surgery for the treatment of idiopathic scoliosis.
Osteotomies
Several studies have compared one-column posterior osteoto-
mies with three-column posterior osteotomies for the correc-
tion of spinal deformity. While greater correction is achieved
with three-column osteotomies, this technique is associated
with greater blood loss, greater neurologic risk, and higher
overall complication rates. The role of either posterior one-
column or three-column osteotomies is gaining importance for
the treatment of sagittal imbalance. Determination of the ap-
propriate cephalad instrumented vertebra in adult spinal de-
formity remains a challenge. Controversy remains with regard
to what factors impact the outcome of fusions that extend to
the upper or lower thoracic spine, but long-term evaluations
now clearly favor extension of the fusion to the sacrum instead
of L5 in the adult population.
Patient-Reported Outcomes
Previous studies suggested the SRS-22 outcomes tool was not
responsive to the effects of surgical treatment of adolescent
idiopathic scoliosis, but several reports at the 2009 Scoliosis
Research Society (SRS) annual meeting suggested the contrary.
A substantial percentage of patients with adolescent idiopathic
scoliosis reported reduction in pain, improved appearance, and
high satisfaction with surgical treatment. For the adult pop-
ulation, the SRS, Oswestry Disability Index (ODI), and SF-12
outcomes tools seemed to reflect improvement following sur-
gical treatment. On the SF-12, improvement in the physical
component was consistent but improvement in the mental
component proved to be inconsistent. Of the three measures,
the SRS-22 seems to be the most sensitive to change as a result
of surgical treatment.
Complications
The rate of postoperative blindness complicating long spinal
surgery with the patient in the prone position is 1 in 1000
(0.1%). This devastating complication is as feared as paralysis.
Visual-evoked potentials have been suggested as a potential
monitoring tool. Recommendations include keeping all pres-
sure off the eyes, having the head and face higher than the rest
of the body, and avoiding long periods of hypotension if the
surgery lasts for more than six hours.
The SRS Morbidity and Mortality Committee analyzed
postoperative infection: 108,419 cases were identified, with
a 0.8% rate of superficial infection and a 1.3% rate of deep
infection. The conclusion of the Morbidity and Mortality
Committee was that ‘‘post-surgical infection, even among
skilled spine surgeons, is an inherent potential complication.’’
Among the adult population, the highest deep infection rates
were found in patients with kyphotic and degenerative scoli-
osis. In the pediatric population, neuromuscular kyphosis
was associated with the highest rate of deep infection,
approaching 10%.
What’s New in Spinal Cord Injury
Injuries involving the spinal cord continue to be devastating.
Recent research efforts have focused on the timing of surgical
intervention and the use of newly developed pharmaceutical
agents to minimize injury or to promote nerve regeneration,
with several of these drugs involved in human trials. The use
of methylprednisolone continues to be controversial, with
emerging evidence arguing against its use.
Evaluation and Management
Proper evaluation of traumatic spinal cord injuries and care
at an appropriate facility is essential. In a recent review of
approximately 11,000 patients that was published in the Annals of
Surgery, patients with a traumatic spinal cord injury who were
managed at either a level-I or II trauma center were less likely to
have paralysis at the time of discharge (odds ratio, 0.67). In-
terestingly, higher surgical volume, and not admission volume,
was associated with a lower risk of paralysis. Admission to
a trauma center or a non-trauma center did not affect mortality.
Despite recommendations that patients with traumatic spinal
cord injuries be managed at a trauma center, approximately 42%
of patients were cared for at a non-trauma center.
Early decompression has long been believed to be ben-
eficial for the treatment of spinal cord injury, although clinical
evidence to support this belief has been lacking. The Surgical
Treatment for Acute Spinal Cord Injury Study (STASCIS),
a multicenter, randomized clinical trial, is addressing this issue.
In that study, early surgery is defined as that performed within
twenty-four hours after the injury whereas late surgery is
defined as that performed more than twenty-four hours after
the injury. As of August 2009, >400 patients had been enrolled.
While the patients who were managed with both early and
late surgery showed improvement of one American Spinal
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Injury Association grade, a higher percentage of the patients
who were managed with early decompression showed im-
provement of two grades or more and those who were managed
with late decompression were more likely to show no im-
provement or to have a deterioration in neurologic status.
Complication Avoidance
The development of heterotopic ossification, particularly around
the hips, can be a challenging complication following spinal cord
injury. In a recent study from Serbia, patients were randomized to
have no preventive treatment or to receive pulsed low-intensity
electromagnetic field therapy thirty minutes a day, for four weeks,
starting seven weeks after the injury. No patient in the experi-
mental group developed heterotopic ossification, but 33% of
those in the control group did. It is theorized that the electro-
magnetic field treatment may increase blood flow to the areas of
injury, increasing oxygen delivery and toxin removal, which may
aid in the prevention of heterotopic ossification.
Neuroprotective Treatment
The use of methylprednisolone for the treatment of acute
spinal cord injury continues to be controversial. Evidence
supporting its use is derived from the National Acute Spinal
Cord Injury Studies (NASCIS) II and III, although there has
been considerable criticism of the methods used to demon-
strate clinical usefulness. The lack of other effective treatment
options, the high propensity for litigation in cases involving
spinal cord injury, and the paucity of good clinical research
opposing its use has led to methylprednisolone being widely
used in the setting of spinal cord injury, including by 86% of
members of the North American Spine Society. Recently, Ito
et al. reported the results of a prospective cohort study from
Japan in which patients who were managed during the first two
years of the study received steroids, whereas patients who were
managed during the second two years did not. The authors
reported improved neurologic recovery in the group that
did not receive steroids. They also reported a higher rate of
complications in the group that received steroids, including
higher rates of pneumonia and gastrointestinal bleeding. This
study provides strong evidence to those who oppose the use of
steroids for patients with spinal cord injury.
Emerging Therapies
The search for an effective treatment to help to improve
neurologic function in patients with spinal cord injury is on-
going. Several pharmaceutical agents, medical devices, and
interventions are currently undergoing clinical trials. Riluzole
(sanofi-aventis, Bridgewater, New Jersey), a sodium channel-
blocking medication currently approved for the treatment of
amyotrophic lateral sclerosis, has been shown in animal studies
to have neuroprotective properties at the zone of injury and is
currently entered into a Phase-I clinical trial.
Magnesium chloride has previously been shown to have
a beneficial effect in patients with spinal cord injury, but the high
doses necessary to produce a benefit have historically limited its
usefulness. A new formulation incorporating the magnesium in
polyethylene glycol, with the goal of increasing its bioavailability
within the cerebrospinal space, has been developed. A Phase-I
trial was recently completed, and plans are under way for
a Phase-II trial. Cethrin (Alseres Pharmaceuticals, Hopkinton,
Massachusetts) is a Rho GTPase inhibitor that acts to prevent
apoptosis and to promote neurite growth. It has the ability to
penetrate the spinal cord after extradural delivery. Currently,
a combined Phase-I/IIa trial was completed, with no adverse
effects being attributed to Cethrin. ATI355A2102 (Novartis,
Basel, Switzerland) is an anti-Nogo A antibody that has been
shown to promote neurite overgrowth and to promote axonal
regeneration and functional improvement in a monkey model.
An initial human trial is currently under way, and, while the
initial results have shown no adverse effects, the final results
from all arms of the study have yet to be evaluated. GRNOPC1
(Geron, Menlo Park, California), an allogeneic stem-cell-based
therapy injected directly into the zone of injury within seven to
fourteen days after the injury, has demonstrated improved
neurite overgrowth, myelination, and motor function in animal
models. A Phase-I clinical trial had been started, but as of August
18, 2009, the FDA has placed a hold on this study because of
concerns regarding the formation of cysts in the post-injury scar.
Although these cysts are nonproliferative and have
been confined to the zone of injury, the FDA has requested
additional animal studies before continuing with clinical trials.
The draining of cerebrospinal fluid and monitoring of
intrathecal pressure has become routine following the treat-
ment of aortic aneurysms but has not previously been evalu-
ated in the setting of spinal cord injury. In a recent prospective
randomized trial, Kwon et al. evaluated the effect of placement
of a lumbar intrathecal drain and the drainage of cerebrospi-
nal fluid to lower the intrathecal pressure in the setting of spinal
cord injury. The authors suggested that the higher peak in-
trathecal pressures observed postoperatively in the group of
patients who did not receive drainage of cerebrospinal fluid
may have an adverse impact on the perfusion pressure of the
spinal cord. In addition, the authors observed that the cere-
brospinal fluid waveform was dampened initially and then
increased in amplitude following decompressive surgery, sug-
gesting the return of more normal cerebrospinal fluid flow
across the zone of injury, and noted that this could be used
intraoperatively to evaluate whether the decompression that
has been performed is adequate. No change in neurologic
recovery was found, but the small number of patients may
have been inadequate to detect such a change. The authors
suggested that the placement of an intrathecal drain may
provide better monitoring of the perfusion pressure of the
spinal cord following injury.
What’s New in the Treatment of the Lumbar Spine
Lumbar spine disorders continue to be a substantial problem
for the general population, and the cause and treatment of the
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pain generator for lumbar degenerative disease remains
controversial.
Lumbar Disc Degeneration
Lumbar discography is a procedure that is commonly per-
formed in an attempt to localize the pain generator and to
determine whether the disc is the cause of the patient’s low back
pain. A prospective, controlled, matched-cohort study of disc
degeneration, in which patients either had discography or
did not, was performed. Seventy-five subjects without serious
low back pain underwent a magnetic resonance imaging and
discography protocol and were followed over a ten-year period.
A matched group was also enrolled. Fifty patients undergoing
discography and fifty-two control subjects were entered into
the analysis. There was progression of disc degeneration in 35%
of the patients in the discography group, compared with 14%
of the subjects in the control group. There were fifty-five new
disc herniations in the discography group, compared with
twenty-two in the control group. These new disc herniations
were disproportionately found on the side of the anular needle
puncture. There were also more vertebral end plate signal
changes and anular fissures, as well as greater loss of disc height
and signal intensity, in the discography group. These findings
are of concern because of the potential for the discography
procedure to accelerate future disc degeneration.
Another study evaluated the surgery rate in patients
having discography procedures. Two hundred and one con-
secutive patients with disc degeneration underwent discogra-
phy to aid in localization of a possible source of back pain. On
the basis of the results of the discography, 36% of the patients
had recommendations against surgery, primarily based on
a nonconcordant pain profile and three or more levels of
concordant pain during the procedure. The authors concluded
that discography can be a useful tool to identify patients who
are not good candidates for surgery.
The cause of disc degeneration is not known but is thought
to be multifactorial. One study specifically evaluated the effects of
greater body mass on lumbar disc degeneration. Forty-four pairs
of healthy male monozygotic twins with ‡8 kg of discordance in
body weight were entered into the study. The authors found that
higher body weight was associated with 6.2% higher bone
density in the spine. They also found that there were fewer disc
signal irregularities in the heavier twin as compared with the
lighter twin, concluding that cumulative or repetitive loading
due to higher body mass may slightly delay disc desiccation.
Vertebral Compression Fractures
A European multicenter randomized controlled clinical study
was performed on patients with one to three nontraumatic
vertebral compression fractures due to osteoporosis or cancer.
Patients were assigned to either balloon kyphoplasty or non-
operative management. Twenty-one sites in eight countries
enrolled 300 patients. Patients assigned to kyphoplasty had
improved physical component scores, improved global quality
of life, more pain relief, less back disability, fewer days of
limited activity, and less back pain. The authors concluded that
balloon kyphoplasty improved the quality of life and reduced
back pain and disability, without increasing adverse events,
including the risk of vertebral fracture, over a two-year period.
Another study examined the risks of pulmonary cement
embolism after multilevel vertebroplasty. In that study, 148 pa-
tients who had been managed with multilevel vertebroplasty had
postoperative chest radiographs to assess for cement embolism.
After a minimum duration of follow-up of two years, pulmonary
cement embolism was confirmed in eleven patients, five of
whom had pulmonary symptoms. All embolisms occurred in
patients who had treatment of four levels or more, and none
were found in patients who had procedures on different days.
Lumbar Disc Herniation
The length of time that patients with lumbar disc herniations
experience symptoms before treatment and the results of the
treatment are not known. The Spine Patient Outcomes Re-
search Trial (SPORT) examined the correlation between the
duration of symptoms and the results of treatment. The study
involved 927 patients who had had symptoms for six months
or less and 265 patients who had had symptoms for more
than six months. The patients were analyzed as they were
managed and followed for four years. At baseline, patients who
had had symptoms for more than six months were likely to
feel depressed, were less likely to believe that their symptoms
were getting better, and were more likely to prefer surgical
treatment. At the time of follow-up, all primary outcomes were
significantly worse in patients who had had symptoms for more
than six months. In the operative treatment group, patient
satisfaction and the self-rated health trend were significantly
higher among patients who had had symptoms for less than six
months. In the nonoperative treatment group, these outcomes
did not differ between the patients with symptoms for more
than six months and those with symptoms for less than six
months. In both the operative and nonoperative treatment
groups, work status was significantly better in patients who had
had symptoms for six months or less. Within both groups,
the treatment effects were significant for all primary and sec-
ondary outcome measures at all follow-up time periods in favor
of surgery. The authors concluded that increased symptom
duration due to lumbar disc herniations is related to worse
outcomes following both operative and nonoperative treatment.
A genetic predisposition for the development of lumbar
disc disease has been suggested by several previous twin studies
and genetic markers. In one study, 1294 patients with lumbar
disc herniations were identified in a Utah population database. A
comparison of the relatives of these individuals with those of
>5000 patients without any lumbar disc herniations revealed
a significant increase in the risk of disc disease in relatives. The
risk of herniation was significantly elevated in both first and
third-degree relatives. The findings of this study strongly support
a heritable predisposition to lumbar disc herniation.
2023
TH E J O U R N A L O F B O N E & JO I N T SU R G E RY d J B J S . O R G
VO LU M E 92-A d NU M B E R 10 d AU G U S T 18, 2010
WH AT ’s NE W I N SP I N E SU R G E RY
What’s New in Spine Surgery
Preoperative Studies
The relationship between preoperative electromyography
studies and surgical results is not well documented. One study
evaluated fifty-five patients who were evaluated with electro-
myography before undergoing surgical decompression with or
without fusion. The preoperative electromyography studies
were classified as positive or negative, and the patients were
followed with regard to postoperative symptoms. The authors
found that patients with primary extremity pain and a positive
electromyography study had 78.1% improvement at the time of
follow-up. Patients with extremity pain with a negative elec-
tromyography study had only a 20% improvement in terms of
extremity pain. In patients who had primarily axial pain, the
results of electromyography did not correlate with improve-
ment in the back pain.
Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculo-
skeletal system that received a Level of Evidence grade of I. Over
100 medical journals were reviewed to identify these articles, all
of which have high-quality study design. In addition to articles
published previously in this journal or already cited in this
update, twenty-one additional level-I articles were identified
that were relevant to spine surgery. A list of those articles is
appended to this review following the standard bibliography.
We have provided a brief commentary about each of the articles
to help guide your further reading, in an evidence-based
fashion, in this subspecialty area.
Upcoming Meetings and Events Related to Spine Surgery
The EuroSpine Annual Meeting will be held on September 15
through 17, 2010, in Vienna, Austria. Web site:
www.eurospine.org
The Forty-fifth Annual Meeting of the Scoliosis Research
Society (SRS) will be held on September 21 through 24, 2010,
in Kyoto, Japan. It will be preceded by a one-day course entitled
‘‘Cervical Spine Section,’’ to be held on September 21, 2010.
Web site: www.srs.org
The Twenty-fifth Annual Meeting of the North American
Spine Society (NASS) will be held on October 5 through 9, 2010,
in Orlando, Florida. There will be a number of precourses, to be
held on October 4, 2010. Web site: www.spine.org
The Thirty-eighth Annual Meeting of the Cervical Spine
Research Society (CSRS) will be held on December 2 through 4,
2010, in Charlotte, North Carolina. Web site: www.csrs.org
The Federation of Spine Associations will present the
spine program on Specialty Day at the Annual Meeting of the
American Academy of Orthopaedic Surgeons (AAOS) on
February 19, 2011, in San Diego, California. Web site:
www.aaos.org
The Annual Meeting of the American Association of
Neurological Surgeons/Congress of Neurological Surgeons
(AANS/CNS) Section on Disorders of the Spine and Peripheral
Nerves will be held on March 9 through 12, 2011, in Phoenix,
Arizona. Web site: www.spinesection.org
The Spine Arthroplasty Society’s Eleventh Annual Global
Symposium on Motion Preservation Technology will be held
on April 26 through 29, 2011, in Las Vegas, Nevada. Web site:
www.spinearthroplasty.org
The American Spinal Injury Association’s (ASIA) In-
ternational Conference on Spinal Cord Medicine and Re-
habilitation will be held on June 4 through 8, 2011, in
Washington, DC. Web site: www.asia-spinalinjury.org
The Annual Meeting of the International Society for the
Study of the Lumbar Spine (ISSLS) will be held on June 14
through 18, 2011, in Gothenburg, Sweden. Web site:
www.issls.org
The Eighteenth Annual International Meeting on Ad-
vanced Spine Techniques (IMAST) will be held on July 13
through 16, 2011, in Copenhagen, Denmark. Web site:
www.imastonline.com
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Evidence-Based Articles Related to Spine Surgery
Andersen T, Christensen FB, Ernst C, Fruensgaard S, Østergaard J,
Andersen JL, Rasmussen S, Niedermann B, Høy K, Helmig P, Holm R,
Lindblad BE, Hansen ES, Egund N, Bu¨nger C. The effect of electrical
stimulation on lumbar spinal fusion in older patients: a randomized, con-
trolled, multi-center trial: part 1: functional outcome. Spine (Phila Pa 1976).
2009;34:2241-7.
This multicenter randomized controlled study demonstrated sig-
nificantly better two-year improvement in three of four domains of the
Dallas pain questionnaire in patients who had posterolateral fusion with-
out instrumentation and who were managed with direct current stimula-
tion. No differences were observed in terms of walking distance or SF-36
results.
Andersen T, Christensen FB, Egund N, Ernst C, Fruensgaard S, Østergaard J,
Andersen JL, Rasmussen S, Niedermann B, Høy K, Helmig P, Holm R,
Lindblad BE, Hansen ES, Bu¨nger C. The effect of electrical stimulation on
lumbar spinal fusion in older patients: a randomized, controlled, multi-center
trial: part 2: fusion rates. Spine (Phila Pa 1976). 2009;34:2248-53.
In a second study evaluating the radiographic results of a multicenter
randomized trial, a low overall fusion rate occurred both in the group treated
with electrical stimulation and in the group treated without stimulation, with
no difference between the groups. Both this study and the previously men-
tioned study by Andersen et al. showed only a modest effect on outcome and
demonstrated no radiographic improvement as a result of the electrical stim-
ulation. The weaknesses of these studies included the variety of diagnoses and
the potentially poor indications for fusion. Overall, these two studies failed to
demonstrate any positive effect of direct current stimulation for in situ pos-
terolateral lumbar spinal fusion.
Arts MP, Brand R, van den Akker ME, Koes BW, Bartels RH, Peul WC;
Leiden-The Hague Spine Intervention Prognostic Study Group (SIPS).
Tubular diskectomy vs conventional microdiskectomy for sciatica: a random-
ized controlled trial. JAMA. 2009;302:149-58.
In this prospective, randomized trial, 167 patients who had undergone
tubular discectomy were compared with 161 patients who had undergone
conventional discectomy. Patients were followed for one year and were assessed
with use of the Roland-Morris Disability Questionnaire, visual analog pain
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scores, and patient self-assessed recovery. There was no significant difference
between the two methods in terms of Roland-Morris disability scores, but
patients managed with tubular discectomy reported significantly worse leg and
back visual-analog pain scores and self-assessed recovery scores. This well-
done, level-I study disputes the findings of previous studies suggesting the
superiority of minimally invasive surgery procedures and supports the con-
tinued use of conventional microdiscectomy.
Bakker EW, Verhagen AP, van Trijffel E, Lucas C, Koes BW. Spinal me-
chanical load as a risk factor for low back pain: a systematic review of pro-
spective cohort studies. Spine (Phila Pa 1976). 2009;34:E281-93.
This systematic review of the literature specifically assessed the effect of
spinal mechanical load as a risk factor for low back pain. The authors evaluated
the spinal mechanical load at work and during leisure activities in adults
who were free of low back pain at the time of the baseline evaluation. They
evaluated eighteen studies with a total of 24,315 subjects and found strong
evidence that leisure-time sporting activities or exercises, sitting, and prolonged
standing or walking are not associated with low back pain. There was con-
flicting evidence regarding the association between low back pain and leisure
activities, whole-body vibration, nursing tasks, heavy physical work, and
working with the trunk in a bent and/or twisted position. There was no evi-
dence of an association between low back pain and sleeping or professional
sporting activities. This excellent article disproves the theory that higher me-
chanical loads increase low back pain.
Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C,
Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for
painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557-68.
Vertebroplasty has become a common treatment for painful osteopo-
rotic vertebral fractures despite limited evidence to support its use. Seventy-
eight patients with one or two painful fractures of less than twelve months’
duration were enrolled in a prospective, randomized, double-blind, placebo-
controlled trial. The authors were not able to find any significant advantage of
vertebroplasty as compared with a sham procedure in patients with painful
osteoporotic fractures. Sixty-eight percent of the patients in this study had
fractures that were more than six weeks old; many surgeons would not consider
vertebroplasty to be appropriate for such patients. There was a trend toward
better outcomes in the vertebroplasty group, so it is possible that the study was
underpowered to assess the benefit of vertebroplasty in patients with non-
chronic vertebral fractures.
Carreon LY, Glassman SD, Djurasovic M, Campbell MJ, Puno RM, Johnson
JR, Dimar JR 2nd. RhBMP-2 versus iliac crest bone graft for lumbar spine
fusion in patients over 60 years of age: a cost-utility study. Spine (Phila Pa 1976).
2009;34:238-43.
In this randomized clinical trial, patients who were more than sixty
years of age who required decompression and posterolateral fusion were ran-
domized to treatment with either rhBMP-2 or iliac crest bone graft. Patients
who received iliac crest bone graft had more complications and an increased
need for additional treatment and revision surgery in comparison with those
who received rhBMP-2. Higher costs and lower improvement were seen in the
group of patients who received iliac crest bone graft as compared with those
who received rhBMP-2. This excellent article supports the benefits of rhBMP-2
over iliac crest bone graft for posterior lumbar fusion.
Cherkin DC, Sherman KJ, Avins AL, Erro JH, Ichikawa L, Barlow WE,
Delaney K, Hawkes R, Hamilton L, Pressman A, Khalsa PS, Deyo RA. A
randomized trial comparing acupuncture, simulated acupuncture, and usual
care for chronic low back pain. Arch Intern Med. 2009;169:858-66.
This randomized trial compared acupuncture treatments in 638 pa-
tients with chronic low back pain. Ten treatments were provided over seven
weeks and consisted of either individualized acupuncture, standardized acu-
puncture, simulated acupuncture, or usual care. All of the acupuncture treat-
ments were associated with significant improvements on mean dysfunction
scales, and patients who had been managed with acupuncture were more likely
to experience clinically meaningful improvements in terms of dysfunction, but
not in terms of symptoms, as compared with the usual-care group at one year.
Although acupuncture appeared to show some efficacy, the mechanism of
action is unclear, especially when the simulated acupuncture group may rep-
resent a placebo effect. This excellent article evaluates some of the non-
traditional treatments for low back pain and may affect the use of these
modalities.
Chou R, Atlas SJ, Stanos SP, Rosenquist RW. Nonsurgical interventional
therapies for low back pain: a review of the evidence for an American
Pain Society Clinical Practice Guideline. Spine (Phila Pa 1976). 2009;34:
1078-93.
This systematic review of the literature, conducted through July 2008,
assessed the benefits of nonsurgical interventional therapies for low back pain
and radicular pain. The authors found that for sciatica or a prolapsed lumbar
disc with radiculopathy, there was good evidence that chemonucleolysis is
moderately superior to placebo injections but is inferior to surgery. Epidural
steroid injections were moderately effective for short-term but not long-term
relief. There was fair evidence that spinal cord stimulation was moderately
effective for failed back surgery syndrome with persistent radiculopathy, al-
though device-related complications were common. There was good or fair
evidence that prolotherapy, facet joint injection, intradiscal steroid injections,
and percutaneous intradiscal radiofrequency thermocoagulation are not ef-
fective. There was insufficient evidence to reliably evaluate other interventional
therapies. This outstanding article examines the lack of data for many of the
therapeutic strategies for low back pain.
Chou R, Baisden J, Carragee EJ, Resnick DK, Shaffer WO, Loeser JD. Surgery
for low back pain: a review of the evidence for an American Pain Society
Clinical Practice Guideline. Spine (Phila Pa 1976). 2009;34:1094-109.
This systematic review of the literature, conducted through July 2008,
examined the surgical treatments for low back pain. After an extensive search of
the literature, the authors found that surgery for herniated discs associated with
radiculopathy or symptomatic spinal stenosis demonstrates short-term benefits
in comparison with nonoperative treatments, although these benefits can di-
minish with time. For low back pain with degenerative changes without radi-
culopathy, fusion is no more effective than intensive rehabilitation but is
associated with moderate benefits in comparison with standard nonoperative
therapy. This study represents an excellent literature-based review of the
treatments for low back pain.
Dai LY, Jiang LS, Jiang SD. Posterior short-segment fixation with or without
fusion for thoracolumbar burst fractures. A five to seven-year prospective
randomized study. J Bone Joint Surg Am. 2009;91:1033-41.
The authors compared short-segment pedicular fixation with or
without posterolateral fusion for the treatment of thoracolumbar stable-type
burst fractures (fractures with no posterior ligamentous injury). Results at five
to seven years showed no differences between groups. Implant-related com-
plications were not different between the groups, and, surprisingly, implant
removal was not required in patients without fusion. This study suggests that
fixation without fusion is an option for patients with stable-type injuries;
however, whether this generalizes to patients with greater heights and body
mass indices as are seen in North America is unknown.
Han X, Zhu Y, Cui C, Wu Y. A meta-analysis of circumferential fusion versus
instrumented posterolateral fusion in the lumbar spine. Spine (Phila Pa 1976).
2009;34:E618-25.
The meta-analysis included four randomized controlled trials involving
437 patients with a primary diagnosis of low back pain with or without leg pain.
The meta-analysis demonstrated that both procedures resulted in significant
clinical benefit, although no difference was observed between the two tech-
niques. Complication rates and fusion success rates were higher in the patients
managed with circumferential fusion, whereas reoperation rates were lower.
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The weaknesses of this study include the low number of studies and patients,
variations in surgical indications, and inconsistent surgical techniques, which
limit the generalization of any conclusions.
Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond
TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B,
Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of verte-
broplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569-79.
In this multicenter, prospective randomized trial, 131 patients with one
to three painful vertebral compression fractures were managed with either
vertebroplasty or a simulated procedure without cement (control group). The
study did not show a significant improvement with regard to pain in the ver-
tebroplasty group but did show a trend toward a meaningful improvement in
terms of pain in the vertebroplasty group and a higher treatment crossover rate
at three months in the control group. Perhaps the study lacked sufficient power
to demonstrate these differences between groups. It is also worth noting that the
authors had to lower the entry criteria to accept a pain level of 3 of 10, which
many clinicians would not consider to be high enough to warrant a procedural
intervention. The authors should be praised for their attempt to attain level-I
evidence, but care must be taken before extrapolating this conclusion to the
subset of patients with substantial levels of persistent pain at two to four weeks
after acute vertebral fracture. That was not really the group of patients included
in this study.
Koc Z, Ozcakir S, Sivrioglu K, Gurbet A, Kucukoglu S. Effectiveness of
physical therapy and epidural steroid injections in lumbar spinal stenosis. Spine
(Phila Pa 1976). 2009;34:985-9.
This randomized, single-blind controlled trial compared the effects
of epidural steroid injections and physical therapy on pain and function in
patients with lumbar spinal stenosis. Twenty-nine patients were random-
ized into three groups. Group 1 had inpatient physical therapy for two
weeks, Group 2 had epidural steroid injections, and Group 3 was the
control group. Each patient received diclofenac and participated in a home
exercise program. Follow-up was at six months. All groups demonstrated
significant improvements in terms of pain and function, with the group
receiving epidural injections showing a significant improvement over
controls at the two-week time point. The authors showed that both epidural
injections and physical therapy seemed to be effective treatments in this
group of patients with lumbar spinal stenosis at the time of the six-month
follow-up. This was an excellent study looking at conservative treatments in
a prospective manner, and we believe that it may affect what we prescribe
for our patients.
Kuijper B, Tans JT, Beelen A, Nollet F, de Visser M. Cervical collar or
physiotherapy versus wait and see policy for recent onset cervical radiculo-
pathy: randomised trial. BMJ. 2009;339:b3883.
Two hundred and five patients with acute cervical radiculopathy were
randomized to cervical collar, physical therapy, or observational treatment and
were assessed at three weeks, six weeks, and six months. Treatment with either
a collar or physical therapy resulted in statistically significant and clinically
important benefit in comparison with no treatment at three and six weeks, but
no differences were seen at six months as all patients demonstrated improve-
ment. This well-done study demonstrates that wearing a collar or participating
in active exercise programs is associated with early clinical benefit in patients
with acute cervical radiculopathy.
Murrey D, Janssen M, Delamarter R, Goldstein J, Zigler J, Tay B, Darden B.
Results of the prospective, randomized, controlled multicenter Food and Drug
Administration Investigational Device Exemption study of the ProDisc-C total
disc replacement versus anterior discectomy and fusion for the treatment of
1-level symptomatic cervical disc disease. Spine J. 2009;9:275-86.
This prospective, randomized, controlled clinical trial, performed in
accordance with FDA guidelines, assessed the ProDisc-C cervical total disc
replacement. Fusion was compared with total disc replacement. Thirteen sites
participated, and randomization was 1:1. By all measures, the ProDisc-C total
disc replacement was equivalent or superior to fusion in terms of the clinical
outcomes measured. This is a very good study that strongly supports that total
disc replacement may be superior to anterior discectomy and fusion for one-
level pathology in the cervical spine.
Okada S, Maeda T, Ohkawa Y, Harimaya K, Saiwai H, Kumamaru H,
Matsumoto Y, Doi T, Ueta T, Shiba K, Iwamoto Y. Does ossification of the
posterior longitudinal ligament affect the neurological outcome after traumatic
cervical cord injury? Spine (Phila Pa 1976). 2009;34:1148-52.
The purpose of this retrospective study was to assess whether ossifica-
tion of the posterior longitudinal ligament affects neurologic outcomes in
patients with acute cervical spinal cord injury. One hundred and twenty-nine
patients were studied for the duration of their hospital stay, and no evidence
was found that ossification of the posterior longitudinal ligament had any effect
on the initial neurologic status or recovery in motor function after traumatic
cervical cord injury. This study suggests that the presence of asymptomatic
ossification of the posterior longitudinal ligament does not substantially in-
crease the risk of adverse outcomes following subsequent traumatic events
affecting the cervical spinal cord.
Riina J, Anderson PA, Holly LT, Flint K, Davis KE, Riew KD. The effect of an
anterior cervical operation for cervical radiculopathy or myelopathy on asso-
ciated headaches. J Bone Joint Surg Am. 2009;91:1919-23.
The authors performed a post hoc analysis of randomized controlled
trails comparing cervical arthroplasty with fusion to assess the frequency and
severity of associated cervicogenic headache at baseline and at the time of
follow-up. Headache was a major complaint in 86% of patients, with 56% of
patients rating it as severe. Surgery resulted in rapid palliation, with two-
thirds of patients noting sustained improvement whereas about 10% had
worsening. Surprisingly, results were better in the arthroplasty group. This
well-done study confirms that cervicogenic headache is a substantial problem
and that patients can be counseled that improvement is likely following
surgery.
Thalgott JS, Fogarty ME, Giuffre JM, Christenson SD, Epstein AK, Aprill C.
A prospective, randomized, blinded, single-site study to evaluate the clinical
and radiographic differences between frozen and freeze-dried allograft when
used as part of a circumferential anterior lumbar interbody fusion procedure.
Spine (Phila Pa 1976). 2009;34:1251-6.
In this prospective randomized trial, the authors compared two
methods of femoral ring allograft preparation, freeze-dried and fresh-frozen,
used for anterior lumbar interbody fusion. Patients were followed for twenty-
four months and were assessed with regard to fusion, complications, functional
outcome, and pain. Both methods of graft preparation were noted to be as-
sociated with similar pain and outcomes scores. Patients managed with freeze-
dried allografts had a higher rate of pseudarthrosis, with six patients requiring
revision, as compared with only one patient from the fresh-frozen cohort. This
study adds to growing concerns with the use of freeze-dried allografts and
supports the continued use of fresh-frozen allografts despite the increased costs
and difficulties associated with storage.
Walton DM, Pretty J, MacDermid JC, Teasell RW. Risk factors for persistent
problems following whiplash injury: results of a systematic review and meta-
analysis. J Orthop Sports Phys Ther. 2009;39:334-50.
Whiplash-associated disorder is the most commonly reported injury
following motor-vehicle accidents. A systematic review and meta-analysis was
performed from eleven cohorts (n = 3193) to identify factors that might predict
a poor prognosis. No postsecondary education, female sex, a history of previous
neck pain, a baseline neck pain intensity >55 of 100, the presence of neck pain at
baseline, the presence of headache at baseline, catastrophizing, a whiplash-
associated disorder grade of 2 or 3, and no seat belt in use at the time of
collision were the nine factors that were found to be significant predictors on
the basis of the odds ratio and confidence limits.
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Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB,
Ranstam J, Eastell R, Shabe P, Talmadge K, Boonen S. Efficacy and safety of
balloon kyphoplasty compared with non-surgical care for vertebral com-
pression fracture (FREE): a randomised controlled trial. Lancet.
2009;373:1016-24.
This randomized controlled trial was performed at twenty-one sites in
eight countries. One hundred and forty-nine patients received kyphoplasty, and
151 received nonoperative care. The study was funded by Medtronic Spine.
Adverse events did not differ between the groups. The one-month SF-36
physical component score improved significantly more in the kyphoplasty
group than in the nonoperative treatment group. This is a very well-done study,
although funded by industry, that suggests that kyphoplasty should strongly be
considered in this class of patients.
Weinstein JN, Lurie JD, Tosteson TD, Zhao W, Blood EA, Tosteson AN,
Birkmeyer N, Herkowitz H, Longley M, Lenke L, Emery S, Hu SS. Surgical
compared with nonoperative treatment for lumbar degenerative spondy-
lolisthesis. Four-year results in the Spine Patient Outcomes Research Trial
(SPORT) randomized and observational cohorts. J Bone Joint Surg Am.
2009;91:1295-304.
The authors present the four-year results of the randomized and ob-
servational arms of the Spine Patient Outcomes Research Trial (SPORT) for
patients with degenerative spondylolisthesis. The Oswestry Disability Index and
SF-36 were used for outcomes assessments. In the randomized cohort, both
operative and nonoperative treatment groups experienced high rates of
crossover, with 54% of patients in the nonoperative treatment group un-
dergoing surgery and 34% of the operative treatment group instead continuing
with nonoperative care. An intent-to-treat analysis demonstrated no difference
between operative and nonoperative care; however, the as-treated analysis
demonstrated significantly greater improvement in the operatively managed
patients as compared with the nonoperatively managed patients. This study
adds to the growing data from the SPORT study and suggested continued good
intermediate-term results following surgery for the treatment of degenerative
lumbar spondylolisthesis.
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